Home / Inspections / 717213

FDA Inspection 717213 — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. — FEI 1033845

The FDA completed an inspection of Janssen Pharmaceuticals, Inc. on February 18, 2011 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athens, GA (United States)

Facility

Other inspections at this facility

  • 1259762 (VAI Fri Jan 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1025904 (NAI Fri Jul 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 867768 (NAI Thu Feb 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 574811 (NAI Fri Mar 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources